Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Context Therapeutics Inc. (CNTX) had Free Cash Flow per Share of $-0.12 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-8.68M |
|
-- |
|
-- |
|
$9.34M |
|
$-9.34M |
|
$0.66M |
|
$-8.68M |
|
$-8.68M |
|
$-8.68M |
|
$-8.68M |
|
$-8.68M |
|
$-8.68M |
|
$-9.34M |
|
$-9.34M |
|
95.18M |
|
95.18M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$58.52M |
|
$0.06M |
|
$0.34M |
|
$58.86M |
|
$6.53M |
|
-- |
|
$0.12M |
|
$6.66M |
|
$52.20M |
|
$52.20M |
|
$52.20M |
|
91.88M |
|
| Cash Flow Statement Financials | |
$-11.43M |
|
$-0.04M |
|
-- |
|
$66.00M |
|
$54.53M |
|
$-11.47M |
|
$0.41M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.96 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-11.47M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-16.63% |
|
-16.63% |
|
-14.75% |
|
-16.63% |
|
$0.57 |
|
|
Free Cash Flow per Share |
$-0.12 |
$-0.12 |
|